Blannin
Andrew Blannin, Birmingham GB
Patent application number | Description | Published |
---|---|---|
20140149937 | VISUAL MEAL CREATOR - Technologies are generally described for devices, methods and systems effective to create a visual display of a meal. A processor may be configured in communication with a memory. The processor may be effective to display images of food items on a display. The processor may be further configured to receive one or more selections of food items from among the displayed images. The processor may be further configured to display images of the one or more selected food items on the display to generate the visual display of the meal. The processor may be further configured to calculate an amount of energy associated with the displayed meal. | 05-29-2014 |
Beata Maria Blannin, Richmond AU
Patent application number | Description | Published |
---|---|---|
20100239631 | THIOPYRIMIDINE-BASED COMPOUNDS AND USES THEREOF - The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases. | 09-23-2010 |
Beata Maria Blannin, Seabrook AU
Patent application number | Description | Published |
---|---|---|
20140045848 | THIOPYRIMIDINE-BASED COMPOUNDS AND USES THEREOF - The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases. | 02-13-2014 |
20140051703 | THIOPYRIMIDINE-BASED COMPOUNDS AND USES THEREOF - The present invention relates to thiopyrimidine-based compounds that are inhibitors of protein kinases including JAK kinases. In particular, the compounds are selective for JAK1, JAK2 or JAK3 kinases and combinations thereof such as JAK1 and JAK2. The kinase inhibitors can be used in the treatment of kinase associated diseases such as immunological and inflammatory diseases including organ transplants; hyperproliferative diseases including cancer and myeloproliferative diseases; viral diseases; metabolic diseases and vascular diseases. | 02-20-2014 |